Back |
home / stock / uncy / uncy message board
Subject | By | Source | When |
---|---|---|---|
https://ih.advfn.com/common/images/news/NDAQGNW2.jpg | harry crumb | investorshub | 03/06/2023 3:17:41 PM |
Halted again | harry crumb | investorshub | 03/06/2023 2:49:57 PM |
Didnt c one | harry crumb | investorshub | 03/06/2023 2:47:46 PM |
EXTENSION****NASDAQ*** WHEN , DENIED OR NOT, IS THERE | TIMGZ | investorshub | 03/06/2023 2:45:03 PM |
Anyone here, low floater going up $$$$ | harry crumb | investorshub | 03/06/2023 2:42:08 PM |
Halted | harry crumb | investorshub | 03/06/2023 2:41:17 PM |
Might drop like a rock at the open | harry crumb | investorshub | 03/06/2023 2:29:05 PM |
4 times! | harry crumb | investorshub | 03/06/2023 2:21:14 PM |
15 milly on the OS | harry crumb | investorshub | 03/06/2023 1:51:20 PM |
In an out 3 times already | harry crumb | investorshub | 03/06/2023 1:47:05 PM |
Could be a mover today, already up premarket | harry crumb | investorshub | 03/06/2023 1:09:20 PM |
Unicycive Announces up to $130 Million Financing to | subslover | investorshub | 03/06/2023 12:18:36 PM |
https://www.benzinga.com/general/biotech/23/02/30709440/unicycive-this-biotech-c | GiantRun | investorshub | 02/05/2023 5:26:47 PM |
Yes $NWBO has used and is still using | LessIsMore | investorshub | 01/03/2023 12:15:48 PM |
News, Short Squeeze, Breakout and More Instantly...
Unicycive Therapeutics Inc. Company Name:
UNCY Stock Symbol:
NASDAQ Market:
Unicycive Therapeutics Inc. Website:
LOS ALTOS, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), today announced the issuance of U.S. Pate...
LOS ALTOS, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company or “Unicycive”), today announced that Shalabh Gupta, M.D., Chief E...
– Patients preferred OLC more than 4 to 1 over their prior phosphate binder therapy – – Median daily pill burden reduced by half after switch to OLC – LOS ALTOS, Calif., July 10, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a...